n-acetyltalosaminuronic acid has been researched along with Hepatitis C in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kapila, N; Rahman, AU; Zervos, XB | 1 |
| Chudy, M; Fiedler, SA; Funk, M; Halbauer, J; Heiden, M; Henseler, O; Oberle, D; Scheiblauer, H | 1 |
| Alloway, RR; Cafardi, J; Cardi, M; Cuffy, M; Dao, A; Diwan, T; Govil, A; Kaiser, TE; Loethen, A; Luckett, K; Rike, AH; Shah, SA; Sherman, KE; Woodle, ES | 1 |
3 other study(ies) available for n-acetyltalosaminuronic acid and Hepatitis C
| Article | Year |
|---|---|
Reply.
Topics: Allografts; Hepacivirus; Hepatitis C; Humans; Uronic Acids | 2020 |
Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015).
Topics: Germany; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis C; HIV Infections; HIV-1; Humans; Immunoassay; Mass Screening; Serologic Tests; Uronic Acids | 2019 |
Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
Topics: Adult; Donor Selection; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Prognosis; Risk Factors; Tissue and Organ Procurement; Tissue Donors; Transplant Recipients; Uronic Acids; Viral Load | 2019 |